Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib episode artwork

EPISODE · Jan 28, 2026 · 27 MIN

Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib

from BiotechTV - News · host BiotechTV

He discusses learnings about durability, dosing, biomarkers, and more for this first-in-class target.

He discusses learnings about durability, dosing, biomarkers, and more for this first-in-class target.

NOW PLAYING

Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib

0:00 27:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of BiotechTV - News?

This episode is 27 minutes long.

When was this BiotechTV - News episode published?

This episode was published on January 28, 2026.

What is this episode about?

He discusses learnings about durability, dosing, biomarkers, and more for this first-in-class target.

Can I download this BiotechTV - News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!